Search company, investor...

Oceana Therapeutics

Founded Year



Acquired | Acquired



About Oceana Therapeutics

Oceana Therapeutics is a specialty pharmaceutical company focused on commercializing late-stage and FDA-approved assets. In November 2011, Oceana Therapeutics was acquired by Salix Pharmaceuticals for $300 million in cash.

Headquarters Location

2035 Lincoln Highway

Edison, New Jersey, 08817,

United States


Missing: Oceana Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Oceana Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Oceana Therapeutics News

Salix to Buy Oceana

Nov 10, 2011

By Angela Sormani Salix Pharmaceuticals said it would buy privately held Oceana Therapeutics for $300 million in cash to gain access to Oceana’s urology treatments, wrote Reuters. (Reuters) – Salix Pharmaceuticals Ltd said it would buy privately held Oceana Therapeutics for $300 million in cash to gain access to Oceana’s urology treatments. Oceana Therapeutics’ bowel control treatment Solesta was approved by the U.S. Food and Drug Administration in May. Its other approved treatment, Deflux, is used to treat abnormal flow of urine in children. Salix said Solesta peak-sales could exceed $500 million. Salix expects the deal to modestly add to its 2012 earnings and be highly accretive thereafter. The deal is expected to close in December 2011. Separately, Salix reported third-quarter earnings that beat market estimates and raised its 2011 revenue outlook. Shares of Salix closed at $34.65 on Tuesday on Nasdaq. © 2015 Buyouts Insider / Argosy Group LLC

Oceana Therapeutics Frequently Asked Questions (FAQ)

  • When was Oceana Therapeutics founded?

    Oceana Therapeutics was founded in 2008.

  • Where is Oceana Therapeutics's headquarters?

    Oceana Therapeutics's headquarters is located at 2035 Lincoln Highway, Edison.

  • What is Oceana Therapeutics's latest funding round?

    Oceana Therapeutics's latest funding round is Acquired.

  • Who are the investors of Oceana Therapeutics?

    Investors of Oceana Therapeutics include Salix Pharmaceuticals, New Enterprise Associates, Domain Associates and Quaker BioVentures.

  • Who are Oceana Therapeutics's competitors?

    Competitors of Oceana Therapeutics include Zogenix, EUSA Pharma, Alimera Sciences, Ology Bioservices, Salix Pharmaceuticals and 12 more.

Compare Oceana Therapeutics to Competitors

QOL Medical Logo
QOL Medical

QOL Medical is a specialty pharmaceutical company focused on the gastrointestinal market.

Sirion Holdings

Sirion Holdings is a specialty pharmaceutical company focused on ophthamology drugs

Ikano Therapeutics

Ikano Therapeutics is a specialty pharmaceutical company focused on developing nasally delivered pharmaceutical products with a particular focus on drugs treating pain and disorders related to the central nervous system.

Liaoning Nuokang Medicine

China Nuokang Bio-Pharmaceutical is a China-based biopharmaceutical firm.


Xigen develops therapeutic peptides for a range of diseases.

SpePharm Holding

A European specialty pharmaceutical company dedicated to hospital and specialist drugs.SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.